echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > Collection is not simply repetitive, and so is the market

    Collection is not simply repetitive, and so is the market

    • Last Update: 2022-09-20
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Since the implementation of the "4+7" pilot in March 2019, as of now, 7 batches of 8 rounds of collection and procurement have been carried out, but to some extent, as a normalized industry policy, we still have less understanding of collection and procurement, especially the implementation of the results of the selection of market changes inside and outside the backyard, resulting in a variety of complex impacts


    Therefore, whether it is for the better implementation of policies or to provide more decision-making references for enterprises, it is of great significance


    According to the PDB sample hospital database, we have sorted out the sales and sales changes of 1-5 batches of selected products from 2018 to 2021.


    Figure 1: Changes in the market of 4+7 selected drugs in the collection

    Figure 2: Market changes in the hospital end of the second batch of selected drugs

    Figure 3: Changes in the market of the third batch of selected drugs

    Taking the 4+7 collection as an example, the results of the selection were implemented from March 2019 and December 2019 respectively, and after one or two years of implementation, the provinces carried out renewals, and the renewal results were divided into successful renewals by the selected enterprises and non-selected enterprises


    However, in general, the successful continuation of the selected enterprises accounts for about the majority, ensuring the smooth continuation of the purchase with volume


    In fact, before the collection was carried out, the sales and sales volume of the hospital market mostly maintained a positive growth of more than 10%, and the increase in sales was higher than the increase in sales, indicating that the price of


    The overall trend of change in the second and third batches is similar to that of the first batch, first the volume market diverges, and then the volume market returns (the third batch of collection has not yet observed the regression


    In addition, the gradual rationalization of corporate quotations and the continuous optimization of collection rules have also had a positive impact on


    Again, the impact of collection on the market of selected products is relatively rapid, and the impact is also relatively large


    Figure 4: Market changes in the hospital end of the second batch of selected drugs

    Figure 5: Market changes in the hospital end of the second batch of selected drugs

    We have separated batches 4 and 5 from the previous batches 1-3 because batches 4-5 have shown new characteristics and trends


    This is a positive signal for the selected enterprises, after all, the enterprises are ultimately for the purpose of profit, and the results of the double increase in the volume of the market can further improve the enthusiasm of


    The spillover effect of the collection and procurement we mentioned earlier is verified: it has a price reduction pull effect


    brief summary

    brief summary

    Since the implementation of the collection, the industry has been highly concerned, and the collection is also constantly optimizing the rules and patching loopholes


    It is believed that with the continuous promotion and improvement of collection and mining, the moisture of generic drugs has gradually been squeezed out, and enterprises and collection are expected to form a positive cycle of complementarity, and enterprises can quickly release the amount of collection, seize the market, and achieve reasonable returns, promote the formation of a healthy circulation environment in the industry, drive the transformation and upgrading of the industry, improve the efficiency of the use of medical insurance funds, and maintain the interests of more patients
    .
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.